Vaxart to Present at the Citizens Life Sciences Conference
Vaxart (NASDAQ: VXRT) has announced its upcoming participation in the Citizens Life Sciences Conference, scheduled for May 7-8, 2025. The company's management team will deliver a presentation on Wednesday, May 7 at 1:00 PM ET.
The presentation will be accessible through a live webcast on Vaxart's official website (www.vaxart.com). For those unable to attend the live session, a replay will remain available for 30 days after the event.
Institutional investors interested in engaging with the management team during the conference can coordinate through their Citizens representative.
Vaxart (NASDAQ: VXRT) ha annunciato la sua partecipazione alla Citizens Life Sciences Conference, in programma dal 7 all'8 maggio 2025. Il team di gestione dell'azienda terrà una presentazione mercoledì 7 maggio alle 13:00 ET.
La presentazione sarà accessibile tramite una diretta streaming sul sito ufficiale di Vaxart (www.vaxart.com). Per chi non potrà seguire la sessione in diretta, la registrazione resterà disponibile per 30 giorni dopo l'evento.
Gli investitori istituzionali interessati a interagire con il team di gestione durante la conferenza possono coordinarsi tramite il loro rappresentante Citizens.
Vaxart (NASDAQ: VXRT) ha anunciado su próxima participación en la Conferencia de Ciencias de la Vida de Citizens, programada para los días 7 y 8 de mayo de 2025. El equipo directivo de la empresa realizará una presentación el miércoles 7 de mayo a la 1:00 PM ET.
La presentación estará disponible a través de una transmisión en vivo en el sitio web oficial de Vaxart (www.vaxart.com). Para quienes no puedan asistir en vivo, la grabación estará disponible durante 30 días después del evento.
Los inversores institucionales interesados en interactuar con el equipo directivo durante la conferencia pueden coordinarse a través de su representante de Citizens.
Vaxart (NASDAQ: VXRT)는 2025년 5월 7일부터 8일까지 예정된 Citizens Life Sciences Conference에 참여할 예정임을 발표했습니다. 회사 경영진은 5월 7일 수요일 오후 1시(동부시간)에 발표를 진행할 예정입니다.
발표는 Vaxart 공식 웹사이트(www.vaxart.com)를 통해 실시간 웹캐스트로 시청할 수 있습니다. 생방송에 참석하지 못하는 분들을 위해 발표 후 30일간 다시보기 서비스가 제공됩니다.
컨퍼런스 기간 동안 경영진과 소통을 원하는 기관 투자자는 Citizens 담당자를 통해 조율할 수 있습니다.
Vaxart (NASDAQ : VXRT) a annoncé sa prochaine participation à la Citizens Life Sciences Conference, prévue les 7 et 8 mai 2025. L'équipe de direction de la société fera une présentation le mercredi 7 mai à 13h00 ET.
La présentation sera accessible via une diffusion en direct sur le site officiel de Vaxart (www.vaxart.com). Pour ceux qui ne pourront pas assister en direct, une rediffusion sera disponible pendant 30 jours après l'événement.
Les investisseurs institutionnels souhaitant interagir avec l'équipe de direction durant la conférence peuvent se coordonner via leur représentant Citizens.
Vaxart (NASDAQ: VXRT) hat seine bevorstehende Teilnahme an der Citizens Life Sciences Conference angekündigt, die für den 7. bis 8. Mai 2025 geplant ist. Das Management-Team des Unternehmens wird am Mittwoch, den 7. Mai, um 13:00 Uhr ET eine Präsentation halten.
Die Präsentation wird über einen Live-Webcast auf der offiziellen Website von Vaxart (www.vaxart.com) zugänglich sein. Für diejenigen, die nicht live teilnehmen können, steht eine Aufzeichnung für 30 Tage nach der Veranstaltung zur Verfügung.
Institutionelle Investoren, die während der Konferenz mit dem Management-Team in Kontakt treten möchten, können über ihren Citizens-Vertreter koordinieren.
- Management team's participation in a major life sciences conference indicates active investor outreach
- Live webcast accessibility increases transparency and investor engagement
- None.
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that members of the management team will present at the Citizens Life Sciences conference taking place May 7-8, 2025.
Presentation Details:
Date and Time: Wednesday, May 7 at 1:00 PM ET
Webcast: Click Here
A live webcast will be available on the Company’s website at www.vaxart.com, and a replay of the presentation will be available for 30 days following the conclusion of the event.
Institutional investors interested in meeting with management during the conference may reach out to their Citizens representative.
About Vaxart
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart’s development programs currently include pill vaccines designed to protect against coronavirus, norovirus and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
Contact
Vaxart Media and Investor Relations:
Matt Steinberg
FINN Partners
IR@vaxart.com
(646) 871-8481
This press release was published by a CLEAR® Verified individual.
FAQ
When is Vaxart (VXRT) presenting at the Citizens Life Sciences Conference 2025?
How can I watch Vaxart's (VXRT) presentation at the Citizens Life Sciences Conference?
Where is the Citizens Life Sciences Conference 2025 with Vaxart (VXRT) taking place?
How long will Vaxart's (VXRT) May 2025 conference presentation replay be available?
Can investors schedule meetings with Vaxart (VXRT) management at the Citizens Conference?
